Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 2152353
PUBLISHER: Grand View Research | PRODUCT CODE: 2152353
Middle East And Africa Peripheral Liquid Embolic Agents Market Size, Share & Trends Analysis Report By Product (EVOH, Cyanoacrylates/Tissue Glues Combined), By Application, By End Use, By Country, And Segment Forecasts, 2026 - 2036
PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Middle East And Africa Peripheral Liquid Embolic Agents Market Summary
The Middle East and Africa peripheral liquid embolic agents market size was valued at USD 19.5 million in 2025 and is projected to grow from USD 21.3 million in 2026 to USD 49.6 million by 2036, at a CAGR of 8.8% from 2026 to 2036. The market is driven by the rising prevalence of peripheral vascular disorders, increasing adoption of minimally invasive endovascular procedures, and growing use of embolization techniques in interventional oncology.
Increasing diagnosis and treatment of venous disorders is driving the use of peripheral liquid embolic agents across the Middle East, particularly for patients requiring minimally invasive endovascular procedures. Varicose veins account for a substantial proportion of venous disease cases, with factors such as aging, obesity, prolonged standing, physical inactivity, pregnancy, and chronic venous insufficiency contributing to the need for clinical intervention.
For instance, a study published by the MDPI in 2025, titled "Prevalence of Varicose Veins Among Teaching Professionals and Their Impact on Quality of Life and Job Performance." A cross-sectional study was conducted employing a stratified convenience sampling strategy among 400 school and university educators across different regions of Saudi Arabia. Data collection took place over four months, from mid-January to the end of April 2025.
In addition, expansion of healthcare infrastructure and investment in interventional facilities: The expansion of healthcare infrastructure across the Middle East is supporting the adoption of advanced minimally invasive and image-guided procedures, including embolization interventions. For instance, in February 2026, Aster DM Healthcare announced a Dh1 billion investment in the UAE to expand its healthcare network, including the development of two new hospitals, capacity expansion at an existing facility, and the introduction of advanced medical services. The investment is expected to add approximately 372 beds and create more than 1,000 jobs over the next two to three years. Such investments are strengthening the region's hospital capacity and improving access to specialized and technology-intensive healthcare services. The expansion of advanced clinical infrastructure is expected to increase the availability of facilities capable of performing complex catheter-based and image-guided interventions, thereby creating opportunities for greater adoption of peripheral liquid embolic agents in the UAE and wider Middle East market.
Middle East and Africa Peripheral Liquid Embolic Agents Market Report Segmentation
This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2036. For this study, Grand View Research has segmented the Middle East and Africa peripheral liquid embolic agents market report based on product, application and end use:
- Product Outlook (Revenue, USD Million, 2021 - 2036)
- Ethylene Vinyl Alcohol Copolymer (EVOH)
- Cyanoacrylates/tissue glues combined
- n-butyl cyanoacrylate (n-BCA)
- n-hexyl cyanoacrylate (n-HCA)
- Application Outlook (Revenue, USD Million, 2021 - 2036)
- Peripheral Vascular Hemorrhage
- Hypervascular Tumors
- Peripheral Vascular Malformations/AVMs
- Aneurysms/Pseudoaneurysms
- Type II Endoleaks
- Portal Vein Embolization (PVE)
- Venous Applications (varicocele, PCS, varicose veins)
- End Use Outlook (Revenue, USD Million, 2021 - 2036)
- Hospitals
- Others
- Country Outlook (Revenue, USD Million, 2021-2036)
- Middle East
- North Africa
- South Africa
Product Code: GVR-4-68041-039-0
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End Use
- 1.1.4. Estimates and forecast timeline
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of primary research
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.7.1. Commodity flow analysis (Model 1)
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Middle East and Africa Peripheral Liquid Embolic Agents Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Rising cardiovascular disease burden and peripheral vascular disorders
- 3.2.1.2. Increasing cancer burden and demand for interventional oncology
- 3.2.1.3. Growing adoption of minimally invasive embolization procedures
- 3.2.1.4. Expansion of tertiary hospitals and interventional radiology infrastructure
- 3.2.1.5. Increasing investment in advanced medical imaging and image-guided procedures
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Shortage and uneven distribution of trained interventional radiologists
- 3.2.2.2. Limited access to angiography and advanced imaging infrastructure in lower-resource markets
- 3.2.3. Market Opportunity Analysis
- 3.2.3.1. Increasing use of embolization in hypervascular tumors and interventional oncology
- 3.2.3.2. Growth of private healthcare investment and public-private healthcare partnerships
- 3.2.3.3. Development of physician training and technology-transfer programs in Africa
- 3.2.3.4. Regulatory strengthening and improving medical-device market access across MEA
- 3.2.4. Market Challenge Analysis
- 3.2.4.1. Conflict, political instability, and disruption of healthcare services
- 3.2.1. Market Drivers Analysis
- 3.3. Middle East and Africa peripheral liquid Embolic Agents Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal landscape
- 3.3.1. Porter's Analysis
Chapter 4. Middle East and Africa Peripheral Liquid Embolic Agents Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Middle East and Africa Peripheral Liquid Embolic Agents Market: Product Movement Analysis, 2025 & 2036 (USD Million)
- 4.3. Middle East and Africa Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Product, 2021 to 2036 (USD Million)
- 4.4. Ethylene Vinyl Alcohol Copolymer (EVOH)
- 4.4.1. Ethylene Vinyl Alcohol Copolymer (EVOH) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.5. Cyanoacrylates/tissue glues combined
- 4.5.1. Cyanoacrylates/tissue glues combined market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.5.2. n-butyl cyanoacrylate (n-BCA)
- 4.5.2.1. n-butyl cyanoacrylate (n-BCA) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 4.5.3. n-hexyl cyanoacrylate (n-HCA)
- 4.5.3.1. n-hexyl cyanoacrylate (n-HCA) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 5. Middle East and Africa Peripheral Liquid Embolic Agents Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Middle East and Africa Peripheral Liquid Embolic Agents Market: Application Movement Analysis, 2025 & 2036 (USD Million)
- 5.3. Middle East and Africa Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by Application 2021 to 2036 (USD Million)
- 5.4. Peripheral Vascular Hemorrhage
- 5.4.1. Peripheral Vascular Hemorrhage market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.5. Hypervascular Tumors
- 5.5.1. Hypervascular Tumors market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.6. Peripheral Vascular Malformations/AVMs
- 5.6.1. Peripheral Vascular Malformations/AVMs market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.7. Aneurysms/Pseudoaneurysms
- 5.7.1. Aneurysms/Pseudoaneurysms market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.8. Type II Endoleaks
- 5.8.1. Type II Endoleaks market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.9. Portal Vein Embolization (PVE)
- 5.9.1. Portal Vein Embolization (PVE)market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 5.10. Venous Applications (varicocele, PCS, varicose veins)
- 5.10.1. Venous Applications (varicocele, PCS, varicose veins) market revenue estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 6. Middle East and Africa Peripheral Liquid Embolic Agents Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Middle East and Africa Peripheral Liquid Embolic Agents Market: End Use Movement Analysis, 2025 & 2036 (USD Million)
- 6.3. Middle East and Africa Peripheral Liquid Embolic Agents Market Size & Trend Analysis, by End Use, 2021 to 2036 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2036 (USD Million)
- 6.5. Others
- 6.5.1. Others market revenue estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 7. Middle East and Africa Peripheral Liquid Embolic Agents Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
- 7.1. Country Dashboard
- 7.2. Market Size and Trend Analysis, 2021 to 2036
- 7.3. Middle East and Africa
- 7.3.1. Middle East and Africa peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.2. Middle East
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. Middle East peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.3. North Africa
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. North Africa peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- 7.3.4. South Africa
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. South Africa peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis by Key Market Participants
- 8.2. Company Categorization
- 8.3. Company Market Share Analysis, 2025
- 8.4. Company Heat Map Analysis
- 8.5. Strategy Mapping
- 8.5.1. Expansion
- 8.5.2. Mergers & Acquisition
- 8.5.3. Partnerships & Collaborations
- 8.5.4. New Technology Launches
- 8.5.5. Research And Development
- 8.5.6. Company Profiles
- 8.5.7. Medtronic
- 8.5.7.1. Company overview
- 8.5.7.2. Financial performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic initiatives
- 8.5.8. BALT Group (via Compass Medical Pty Ltd.)
- 8.5.8.1. Company overview
- 8.5.8.2. Financial performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic initiatives
- 8.5.9. GEM S.r.l. (H.B. Fuller Company)
- 8.5.9.1. Company overview
- 8.5.9.2. Financial performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic initiatives
Product Code: GVR-4-68041-039-0
List of Tables
- Table 1 List of Abbreviation
- Table 2 Middle East and Africa peripheral liquid embolic agents market, by product, 2021-2036 (USD Million)
- Table 3 Middle East and Africa peripheral liquid embolic agents market, by application, 2021-2036 (USD Million)
- Table 4 Middle East and Africa peripheral liquid embolic agents market, by end use, 2021-2036 (USD Million)
- Table 5 Middle East peripheral liquid embolic agents market, by product, 2021-2036 (USD Million)
- Table 6 Middle East peripheral liquid embolic agents market, by application, 2021-2036 (USD Million)
- Table 7 Middle East peripheral liquid embolic agents market, by end use, 2021-2036 (USD Million)
- Table 8 North Africa peripheral liquid embolic agents market, by product, 2021-2036 (USD Million)
- Table 9 North Africa peripheral liquid embolic agents market, by application, 2021-2036 (USD Million)
- Table 10 North Africa peripheral liquid embolic agents market, by end use, 2021-2036 (USD Million)
- Table 11 South Africa peripheral liquid embolic agents market, by product, 2021-2036 (USD Million)
- Table 12 South Africa peripheral liquid embolic agents market, by application, 2021-2036 (USD Million)
- Table 13 South Africa peripheral liquid embolic agents market, by end use, 2021-2036 (USD Million)
List of Figures
- Fig. 1 Middle East and Africa peripheral liquid embolic agents market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Data analysis models
- Fig. 5 Market formulation and validation
- Fig. 6 Data validating & publishing
- Fig. 7 Market snapshot
- Fig. 8 Segment snapshot
- Fig. 9 Competitive landscape snapshot
- Fig. 10 Middle East and Africa peripheral liquid embolic agents market size and growth prospects (USD Million)
- Fig. 11 Middle East and Africa peripheral liquid embolic agents market: Industry Value Chain Analysis
- Fig. 12 Middle East and Africa peripheral liquid embolic agents market: Market Dynamics
- Fig. 13 Middle East and Africa peripheral liquid embolic agents market: PORTER's Analysis
- Fig. 14 Middle East and Africa peripheral liquid embolic agents market: PESTEL Analysis
- Fig. 15 Middle East and Africa peripheral liquid embolic agents market share by product, 2025 & 2036 (USD Million)
- Fig. 16 Middle East and Africa peripheral liquid embolic agents market, by product: market share, 2025 & 2036
- Fig. 17 Ethylene Vinyl Alcohol Copolymer (EVOH) market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 18 Cyanoacrylates/tissue glues combined market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 19 n-butyl cyanoacrylate (n-BCA) market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 20 n-hexyl cyanoacrylate (n-HCA) market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 21 Middle East and Africa peripheral liquid embolic agents market share by application, 2025 & 2036 (USD Million)
- Fig. 22 Middle East and Africa peripheral liquid embolic agents market, by application: market share, 2025 & 2036
- Fig. 23 Peripheral vascular hemorrhage market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 24 Hypervascular tumors market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 25 Peripheral vascular malformations/AVMs market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 26 Aneurysms/pseudoaneurysms market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 27 Type II endoleaks market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 28 Portal Vein Embolization (PVE) market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 29 Venous applications (varicocele, PCS, varicose veins) market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 30 Middle East and Africa peripheral liquid embolic agents market share by end use, 2025 & 2036 (USD Million)
- Fig. 31 Middle East and Africa peripheral liquid embolic agents market, by end use: market share, 2025 & 2036
- Fig. 32 Hospitals market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 33 Others market estimates & forecasts, 2021-2036 (USD Million)
- Fig. 34 Country marketplace: key takeaways
- Fig. 35 Middle East peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 36 North Africa peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 37 South Africa peripheral liquid embolic agents market estimates and forecasts, 2021 - 2036 (USD Million)
- Fig. 38 Key company categorization
- Fig. 39 Company market positioning
- Fig. 40 Key company market share analysis, 2025
- Fig. 41 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.